Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shan, J.
Right arrow Articles by Xu, H.-p.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shan, J.
Right arrow Articles by Xu, H.-p.
[Cancer Research 62, 290-294, January 1, 2002]
© 2002 American Association for Cancer Research


Tumor Biology

TSP50, A Possible Protease in Human Testes, Is Activated in Breast Cancer Epithelial Cells1

Jidong Shan, Liming Yuan, Qianxun Xiao, Nicholas Chiorazzi, Daniel Budman, Saul Teichberg and Hao-peng Xu2

Departments of Molecular Oncology [J. S., L. Y., H-p. X.], Pathology [Q. X.], Rheumatology/Clinical Immunology [N. C.], and Electron Microscopy [S. T.] and Hematology/Oncology Medicine [D. B.], North Shore-Long Island Jewish Research Institute, New York University School of Medicine, Manhasset, New York 11030

Initial studies have identified TSP50 as a human testes-specific gene that is demethylated in breast cancer. In this study, we will present new data related to the TSP50 gene. We have found that the TSP50 gene product shares a similar enzymatic structure with many serine proteases. However, the most critical catalytic site, serine, has been replaced by threonine. Western analysis revealed that in human testes, the TSP50 antibody detected two closely positioned protein bands whose estimated molecular masses were 37 kDa, whereas in a large portion of breast cancer tissues, but not normal control tissues, only one band was present. Immunohistochemistry assays found TSP50 proteins located in the spermatocytes of human testes, whereas in situ hybridization and immunohistochemistry confirmed that gene activation in breast tumors took place in malignant mammary epithelial cells. These results suggested that the normal function of the TSP50 gene was involved in spermatogenesis, whereas the up-regulation of TSP50 in many breast cancer patients not only indicated that it might be a novel biomarker for this disease but also encouraged us to further explore the possibility of whether it was an oncogene.




This article has been cited by other articles:


Home page
Cancer Res.Home page
H. Xu, J. Shan, V. Jurukovski, L. Yuan, J. Li, and K. Tian
TSP50 Encodes a Testis-Specific Protease and Is Negatively Regulated by p53
Cancer Res., February 1, 2007; 67(3): 1239 - 1245.
[Abstract] [Full Text] [PDF]


Home page
J Biomol ScreenHome page
J. Wei, Y. Liu, S. Yang, J. Xu, H. Kong, B. Han, Y. Bao, Y. Wu, W. Yin, W. Li, et al.
Screening of Single-Chain Variable Fragments against TSP50 from a Phage Display Antibody Library and Their Expression as Soluble Proteins
J Biomol Screen, August 1, 2006; 11(5): 546 - 552.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.